Endovia Health Sciences, Inc. (EDVA) stock
EDVANYSEBeveragesFiscal year ends December 31
$0.17−0.00 (-1.46%)
Close on Nov 17, 2026Market cap $126.28KP/E –Yield –
Endovia Health Sciences operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Endovia Health Sciences's operating income for the twelve months ending Jun 30, 2026 was -$13.51M. For fiscal 2025 it was -$14.19M. The highest annual figure on record is $66.68K in fiscal 2018.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$14.19M | – |
| FY2024 | Dec 31, 2024 | -$9.90M | – |
| FY2023 | Dec 31, 2023 | -$15.29M | – |
| FY2022 | Dec 31, 2022 | -$21.39M | – |
| FY2021 | Dec 31, 2021 | -$29.08M | – |
| FY2020 | Dec 31, 2020 | -$17.66M | – |
| FY2019 | Dec 31, 2019 | -$4.49M | -6829.7% |
| FY2018 | Dec 31, 2018 | $66.68K | – |
| FY2017 | Dec 31, 2017 | -$157.21K | – |
| FY2016 | Dec 31, 2016 | -$50.00K | -364.6% |
| FY2015 | Dec 31, 2015 | $18.90K | – |
| FY2014 | Dec 31, 2014 | -$27.88K | -4611.0% |
| FY2013 | Dec 31, 2013 | $618 | – |
| FY2012 | Dec 31, 2012 | -$9.32K | – |
| FY2011 | Dec 31, 2011 | -$49.69K | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$2.01M | – |
| Q1 FY2026 | Mar 31, 2026 | -$978.97K | – |
| Q4 FY2025 | Dec 31, 2025 | -$976.41K | – |
| Q3 FY2025 | Sep 30, 2025 | -$9.54M | – |
| Q2 FY2025 | Jun 30, 2025 | -$1.50M | – |
| Q1 FY2025 | Mar 31, 2025 | -$1.66M | – |
| Q4 FY2024 | Dec 31, 2024 | -$289.63K | – |
| Q3 FY2024 | Sep 30, 2024 | -$2.67M | – |
| Q2 FY2024 | Jun 30, 2024 | -$3.69M | – |
| Q1 FY2024 | Mar 31, 2024 | -$3.25M | – |
| Q4 FY2023 | Dec 31, 2023 | -$3.29M | – |
| Q3 FY2023 | Sep 30, 2023 | -$4.32M | – |
| Q4 FY2022 | Dec 31, 2022 | -$4.77M | – |
| Q3 FY2022 | Sep 30, 2022 | -$5.11M | – |
| Q2 FY2022 | Jun 30, 2022 | -$5.83M | – |
| Q1 FY2022 | Mar 31, 2022 | -$5.68M | – |
| Q4 FY2021 | Dec 31, 2021 | -$6.15M | – |
| Q3 FY2021 | Sep 30, 2021 | -$12.07M | – |
| Q2 FY2021 | Jun 30, 2021 | -$6.71M | – |
| Q1 FY2021 | Mar 31, 2021 | -$4.55M | – |
| Q4 FY2020 | Dec 31, 2020 | -$13.36M | – |
| Q3 FY2020 | Sep 30, 2020 | -$2.16M | – |
| Q2 FY2020 | Jun 30, 2020 | -$415.48K | – |
| Q1 FY2020 | Mar 31, 2020 | -$1.55M | – |
| Q4 FY2019 | Dec 31, 2019 | -$2.42M | – |
| Q3 FY2019 | Sep 30, 2019 | -$861.60K | – |
| Q2 FY2019 | Jun 30, 2019 | -$308.15K | -550.0% |
| Q1 FY2019 | Mar 31, 2019 | -$448.48K | -2911.3% |
| Q4 FY2018 | Dec 31, 2018 | -$15.55K | – |
| Q3 FY2018 | Sep 30, 2018 | -$2.21K | -106.7% |
| Q2 FY2018 | Jun 30, 2018 | $68.48K | – |
| Q1 FY2018 | Mar 31, 2018 | $15.95K | – |
| Q4 FY2017 | Dec 31, 2017 | -$107.45K | – |
| Q3 FY2017 | Sep 30, 2017 | $33.07K | – |
| Q2 FY2017 | Jun 30, 2017 | -$21.59K | – |
| Q1 FY2017 | Mar 31, 2017 | -$61.24K | – |
| Q4 FY2016 | Dec 31, 2016 | -$16.07K | – |
| Q3 FY2016 | Sep 30, 2016 | -$12.23K | – |
| Q2 FY2016 | Jun 30, 2016 | -$12.23K | – |
See a number that looks wrong?